For ASA I-II patients, sedation doses are typically:

• A. low end doses
• B. high end doses
• C. standard doses
• D. variable

Answer: (C)

In healthy patients (ASA I–II), sedation is typically started at standard doses and titrated to effect because they usually tolerate sedatives predictably and provide a reliable baseline response. Using standard starting doses gives a consistent starting point, and clinicians adjust upward or downward based on the patient’s response, ensuring the desired level of sedation without oversedation.

Underdosing (low end doses) risks inadequate sedation, leading to poor patient comfort or the need for additional dosing. Oversedation (high end doses) increases the risk of respiratory depression, airway compromise, and hemodynamic instability. A variable approach would create inconsistency and unpredictability in sedation depth, which is not ideal for routine practice in ASA I–II patients.

So the typical approach is standard doses with titration to achieve the desired effect.